Curcumin, a natural compound found in turmeric rhizomes, has been the subject of extensive research due to its potential role in supporting overall health and wellness. Studies have explored its impact on promoting a healthy lifestyle, with particular interest in its nutritional support for maintaining healthy joint function, liver health, and cardiovascular wellness. Additionally, its role in supporting the body’s natural response to inflammation and its antioxidant properties are areas of ongoing research. The ancient Ayurvedic system, which has recognized turmeric for its health-supportive properties for centuries, highlights its use in contributing to overall well-being
With the increasing research into biological functions and activities of curcumin, another area of curcumin biology that is gaining lot of attention is its metabolites.
Curcumin C3 Reduct® is the hydrogenated derivative of the curcuminoids from Curcumin C3 Complex®. It contains a minimum of 95% of Tetrahydrocurcuminoids (THCs) namely Tetrahydrocurcumin (THC), Tetrahydrodemethoxycurcumin (THDMC) and Tetrahydrobisdemethoxycurcumin (THBDMC). It is colourless, tasteless and aesthetically acceptable than curcuminoids (which gives yellow stain).
Curcumin and THC are the major constituents (≥ 75% of the total content) of the turmeric and reduced (hydrogenated) turmeric preparations, respectively. Tetrahydrocurcumin has higher physiological and pharmacological activities than its parent compound. The therapeutic interest for THC lies in its low toxicity and its beneficial biological activities
Keeping in pace with the developing science on the turmeric and its active compounds, Sabinsa presents you the next generation of curcuminoids as Curcumin C3 Reduct®.